Regeneron inks manufacturing and supply agreement with BARDA and U.S. Department of Defense for REGN-COV2 anti-viral antibody cocktail
TARRYTOWN, N.Y. — Regeneron Pharmaceuticals announced Tuesday that, as part of Operation Warp Speed, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, and the Department of Defense Joint Program Executive Office for Chemical, Biological,
